Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza ... PR Newswire (press release) ... in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia. ... |
Binding and activation of host plasminogen on the surface of Francisella ... 7thSpace Interactive (press release) ... (FT) is a Gram-negative facultative intracellular coccobacillus and is the causal agent of a life-threatening zoonotic disease known as tularemia. ... |
FDA aids Advanced Life Sciences Holdings in approval assessment for anthrax drug BioPrepWatch.com ... on the clinical program required to assess the approvability of Restanza, which has been developed to fight anthrax, plague and tularemia, among others. ... www.EquityTradingAlert.com: Reports Hot Stocks To Watch For March 12, 2010 Are ... |
Our Yesterdays 3-8 Augusta Daily Gazette Several cases of tularemia (rabbit fever) had been treated by local doctors. High school students receiving 1 ratings in the league speech festival were ... |
TimelessWealth, Inc.: TimelessWealth.net: OTC Biopharmaceutical News: Entest ... Trading Markets (press release) ... in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia. ... |
